Literature DB >> 2893125

Potential pathogenicity of Leuconostoc.

Y M Coovadia, Z Solwa, J van Den Ende.   

Abstract

Mesh：

Year:  1988        PMID： 2893125     DOI： 10.1016/s0140-6736(88)90395-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Leuconostoc species as a cause of bacteremia: two case reports and a literature review.

Authors:  J C Bernaldo de Quirós; P Muñoz; E Cercenado; T Hernandez Sampelayo; S Moreno; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

2.  Clinical and microbiologic characteristics of pediococci.

Authors:  W J Riebel; J A Washington
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Recovery of vancomycin-resistant gram-positive cocci from children.

Authors:  M Green; R M Wadowsky; K Barbadora
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  Antimicrobial susceptibility of vancomycin-resistant Leuconostoc, Pediococcus, and Lactobacillus species.

Authors:  J M Swenson; R R Facklam; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

5.  Characterization of Leuconostoc lactis strains from human sources.

Authors:  C Barreau; G Wagener
Journal:  J Clin Microbiol       Date:  1990-08       Impact factor: 5.948

Review 6.  Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding the streptococci and enterococci.

Authors:  R Facklam; J A Elliott
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

7.  Successful treatment of Leuconostoc bacteremia in a neutropenic patient with tigecycline.

Authors:  Trupti Patel; Aoife Molloy; Robin Smith; Indran Balakrishnan
Journal:  Infect Dis Rep       Date:  2012-04-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.